This partnership supports the strategic objectives of both organisations to tackle unwarranted health inequalities for Black, ...

An OHE report analyses the rise in NICE’s optimised decisions from 2025 to 2024 and how they affect patient access, HTA ...

The NHS Race and Health Observatory (RHO) has agreed to collaborate with the National Institute for Health and Care Excellence (NICE) to tackle persistent and systemic ethnic health inequalities. The ...

Linzagolix (Yselty) with hormonal add-back therapy will offer a new at-home treatment option for some women in England with ...

As NICE begins to incorporate health equity into drug reimbursement decisions, forward-looking pharmaceutical companies have ...

A new endometriosis pill that could help over 1,000 women manage their symptoms of the condition is now available on the NHS ...

The U.K. National Institute for Health and Care Excellence (NICE) opened a late-stage assessment for drug-eluting stents (DES) with an eye toward costs, advising clinicians that they should implant ...

The once-a-day drug has been recommended for patients with a history of previous medical or surgical treatment ...

Group announced overnight that the National Institute for Health and Care Excellence has issued positive final guidance ...

The National Institute for Health and Care Excellence (NICE) has formally recommended the use of an AI tool for detecting ...

The UK’s National Institute for Health and Care Excellence (NICE) has issued positive final guidance recommending Joenja (leniolisib), from Dutch biopharma company Pharming (Nasdaq: PHAR), for ...

Endometriosis affects around 1.5 million women in the UK but, according to the National Institute for Health and Care Excellence (Nice), diagnosis typically takes nine years from when symptoms ...